- Home
- CVAC vs UPBD Comparison
CVAC vs UPBD Comparison
Compare CVAC & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- UPBD
- Stock Information
- Founded
- CVAC 2000
- UPBD 1986
- Country
- CVAC Germany
- UPBD United States
- Employees
- CVAC N/A
- UPBD N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- UPBD Diversified Commercial Services
- Sector
- CVAC Health Care
- UPBD Consumer Discretionary
- Exchange
- CVAC Nasdaq
- UPBD Nasdaq
- Market Cap
- CVAC 1.2B
- UPBD 1.0B
- IPO Year
- CVAC 2020
- UPBD 1995
- Fundamental
- Price
- CVAC $5.34
- UPBD $17.52
- Analyst Decision
- CVAC Hold
- UPBD Strong Buy
- Analyst Count
- CVAC 3
- UPBD 5
- Target Price
- CVAC $6.83
- UPBD $33.60
- AVG Volume (30 Days)
- CVAC 574.2K
- UPBD 866.2K
- Earning Date
- CVAC 11-12-2025
- UPBD 10-30-2025
- Dividend Yield
- CVAC N/A
- UPBD 8.94%
- EPS Growth
- CVAC N/A
- UPBD N/A
- EPS
- CVAC 1.01
- UPBD 1.45
- Revenue
- CVAC $599,540,810.00
- UPBD $4,577,844,000.00
- Revenue This Year
- CVAC N/A
- UPBD $10.26
- Revenue Next Year
- CVAC $23.40
- UPBD $7.68
- P/E Ratio
- CVAC $5.32
- UPBD $12.03
- Revenue Growth
- CVAC 675.15
- UPBD 7.48
- 52 Week Low
- CVAC $2.37
- UPBD $17.34
- 52 Week High
- CVAC $5.72
- UPBD $36.00
- Technical
- Relative Strength Index (RSI)
- CVAC 51.18
- UPBD 27.09
- Support Level
- CVAC $5.17
- UPBD $17.34
- Resistance Level
- CVAC $5.41
- UPBD $20.09
- Average True Range (ATR)
- CVAC 0.05
- UPBD 1.07
- MACD
- CVAC -0.00
- UPBD -0.34
- Stochastic Oscillator
- CVAC 70.82
- UPBD 1.30
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About UPBD Upbound Group Inc.
Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.